Sandoz Group (OTCMKTS:SDZNY) Hits New 12-Month High – Here’s Why

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY)’s share price reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as $69.63 and last traded at $69.63, with a volume of 24079 shares changing hands. The stock had previously closed at $68.33.

Analysts Set New Price Targets

Several brokerages recently commented on SDZNY. Barclays raised shares of Sandoz Group to a “strong-buy” rating in a research report on Monday, October 13th. Jefferies Financial Group downgraded shares of Sandoz Group from a “strong-buy” rating to a “hold” rating in a research note on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, Sandoz Group currently has a consensus rating of “Moderate Buy”.

Sandoz Group Trading Up 1.2%

The firm has a fifty day simple moving average of $61.65 and a 200-day simple moving average of $56.66. The company has a current ratio of 1.29, a quick ratio of 0.82 and a debt-to-equity ratio of 0.62.

About Sandoz Group

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.